Analysis for LHX
$240.50
+3.00
(+1.26%)
- 📈 Growth — 26/30
- 💰 Profitability — 18/20
- 🏦 Financial Health — 15/20
- 💵 Valuation — 14/20
- ⚠️ Risk — 5/10
Overall Score: 78/100
Summary:
📈 Growth & Financial Trajectory
Over eight quarters, Revenues increased from about $5.21B to $5.88B (≈+13%), while Net Income grew from about $283M to $600M (≈+112%), indicating improving earnings alongside top-line growth.
💰 Margins & Cash Flow
Gross margin stayed in the mid-20s (roughly 24–27%), with Operating Margin expanding from ~9–10% to ~10–11%. Net Cash Flow From Operating Activities was positive in multiple periods (roughly $0.55–0.71B), while investing activity was modestly negative, implying ongoing capital allocation.
🛡️ Balance Sheet & Liquidity
Total Assets around $41–42B; Equity near $19–20B; current assets vs current liabilities yields a conservative liquidity profile (current ratio ~1.1–1.2). Long-term liabilities are substantial but proportionate to the asset base.
⚠️ Key Drivers & Risks
- Driver: Defense program funding and steady government contracting.
- Risks: Budget cycle exposure and potential delays in government spending; sensitivity to defense budget shifts.
📊 Key Financial Fundamentals
Valuation Multiples
Market Cap
$46.35B
P/E Ratio
24.74
Forward P/E
21.28
P/S Ratio
2.02
P/B Ratio
2.70
EV / EBITDA
17.84
Profitability & Returns
Gross Margin
25.48%
Operating Margin
10.12%
Net Margin
8.17%
ROE
9.41%
ROIC
6.00%
Financial Health & Liquidity
Current Ratio
1.18
Quick Ratio
1.03
Financial Scale & Cash Flow
Revenue
$22.93B
Net Income
$1.87B
FCF Yield
6.48%
Free Cash Flow
$3.00B
Total Debt To Equity
0.53